양성 전립선 비대증 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Benign Prostatic Hyperplasia Treatment Market size is expected to reach USD 5.53 Billion in 2034 from USD 2.46 Billion (2025) growing at a CAGR of 9.41% during 2026-2034.

The Global Benign Prostatic Hyperplasia Treatment Market is growing steadily due to the increasing aging male population and rising awareness of prostate health. Higher diagnosis rates and improved access to urological care have strengthened treatment demand. Pharmaceutical therapies and minimally invasive procedures continue to gain traction, contributing to market expansion across both developed and emerging regions.

Key drivers include technological advancements in minimally invasive surgical procedures, improved combination drug therapies, and rising healthcare spending. Greater patient preference for outpatient treatments with shorter recovery times is encouraging device adoption. Increased awareness campaigns and routine health screenings also contribute to early diagnosis and consistent treatment uptake.

Future prospects remain positive as innovation in medical devices and pharmacological treatments continues. Development of advanced laser therapies and non-invasive treatment options is expected to enhance patient outcomes. Companies focusing on cost-effective, patient-friendly solutions and expanding presence in emerging markets are likely to experience steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

• Minimal Invasive Surgery
• Invasive Surgery

By Procedure

• Transurethral Resection Of The Prostate
• Prostate Laser Surgery
• Transurethral Microwave Thermotherapy
• Transurethral Needle Ablation Of The Prostate
• Prostatic Urethral Lift
• Water Vapor Therapy
• Robot-assisted Laparoscopic Prostatectomy
• Aquablation Therapy
• Prostatic Artery Embolization
• Open Prostatectomy
• Bipolar Enucleation Of Prostate
• Transurethral Incision Of The Prostate
• High-Intensity Focused Ultrasound

By Product

• Resectoscopes
• Urology Laser
• Radiofrequency Ablation
• Electrodes
• Catheters
• Prostatic Stents
• Implants
• Others

By End-use

• Hospitals
• Specialty Facilities
• Research & Manufacturing

COMPANIES PROFILED

• Karl Storz, Boston Scientific Corporation, Olympus America, Endo Pharmaceuticals Inc, biolitec AG, Medifocus, Cook Medical, Teleflex Incorporated, Urotronic, Coloplast Corp, Richard Wolf GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment
• 4.2. Minimal Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Transurethral Resection Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Prostate Laser Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transurethral Microwave Thermotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Transurethral Needle Ablation Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Prostatic Urethral Lift Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Water Vapor Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Robot-assisted Laparoscopic Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Aquablation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Prostatic Artery Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Open Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Bipolar Enucleation Of Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Transurethral Incision Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.14. High-Intensity Focused Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. Resectoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Urology Laser Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Radiofrequency Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Electrodes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Prostatic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Treatment
  • 8.2.2 By Procedure
  • 8.2.3 By Product
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Treatment
  • 8.3.2 By Procedure
  • 8.3.3 By Product
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Treatment
  • 8.4.2 By Procedure
  • 8.4.3 By Product
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Treatment
  • 8.5.2 By Procedure
  • 8.5.3 By Product
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Treatment
  • 8.6.2 By Procedure
  • 8.6.3 By Product
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Karl Storz
  • 10.2.2 Boston Scientific Corporation
  • 10.2.3 Olympus America
  • 10.2.4 Endo Pharmaceuticals Inc
  • 10.2.5 Biolitec AG
  • 10.2.6 Medifocus
  • 10.2.7 Cook Medical
  • 10.2.8 Teleflex Incorporated
  • 10.2.9 Urotronic
  • 10.2.10 Coloplast Corp
  • 10.2.11 Richard Wolf GmbH